Haojie Zhu Wins JBC/Herb Tabor Young Investigator Award
The Journal of Biological Chemistry (JBC) has named Haojie Zhu, PhD, the winner of the JBC/Herb Tabor Young Investigator Award. The JBC/Herbert Tabor Young Investigator Award honors Dr. Tabor’s invaluable contributions to science as well as the next generations of researchers who exemplify Dr. Tabor’s values of creativity and scientific excellence.
The JBC associate editors select promising young researchers at scientific symposia and meetings throughout the year. Students, postdoctoral researchers, and faculty members who’ve not yet received tenure are eligible. Dr. Zhu was recognized during the 21st International Symposium on Microsomes and Drug Oxidations (October 2-6, Davis, CA).
“I am honored to receive the JBC/Herb Tabor Award for my work on quantitative proteomics of drug-metabolizing enzymes,” says Dr. Zhu. “A better understanding of interindividual variability in the expression of drug-metabolizing enzymes will lead to a more personalized therapeutic regimen and improved outcomes for patients.”
Dr. Zhu joined the U-M College of Pharmacy as an assistant professor in the Department of Clinical Pharmacy in 2013. His laboratory has developed a novel approach combining pharmacogenomics and proteomics for identification and characterization of genetic and non-genetic biomarkers that are associated with interindividual variability in drug response. These biomarkers could eventually be utilized in clinical practice to improve the efficacy and safety of pharmacotherapy.
Dr. Zhu graduated from the China Pharmaceutical University with a major in Pharmacy, and further received his M.S. and Ph.D. in Pharmacology from the same University. He also holds a MBA degree from Nanjing University. He was a licensed Pharmacist as well as a trained Dentist in China. Dr. Zhu completed his post-doctoral training in Pharmacogenomics, Pharmacokinetics, and Neuropsychopharmacology at the Medical University of South Carolina.
